Download PDF
Exp Clin Endocrinol Diabetes 2014; 122(03): 154-162
DOI: 10.1055/s-0033-1363685
Article
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Spironolactone and Dimethylsulfoxide Effect on Glucose Metabolism and Oxidative Stress Markers in Polycystic Ovarian Syndrome Rat Model

A. Dăneasă   *
1   Department of Physiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
C. Cucolaș   *
1   Department of Physiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
M. Furcea
1   Department of Physiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
P. Bolfa
2   Department of Pathology, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania
,
S. Dudea
3   Department of Radiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
D. Olteanu
1   Department of Physiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
M. C. Alupei
4   Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babeş-Bolyai University, Cluj-Napoca, Romania
5   Molecular Biology Center, Institute for Interdisciplinary Research in ­Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Romania
,
A. Mureșan
1   Department of Physiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
G. A. Filip
1   Department of Physiology, ‘‘Iuliu Haţieganu’’ University of Medicine and Pharmacy, Cluj-Napoca, Romania
› Author Affiliations
Further Information

Publication History

received 16 August 2013
first decision 30 October 2013

accepted 06 December 2013

Publication Date:
18 March 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Because polycystic ovarian syndrome (PCOS) is a risk factor for type 2 diabetes, the affected women can present frequently prediabetic states such as impaired fasting glycaemia and/or impaired glucose tolerance. The purpose of our study is to explore the effect of antiandrogenic spironolactone on glucose metabolism and oxidative stress (OS) parameters in oestradiol valerate (OV) induced PCOS rat model.

72 female Wistar rats were distributed either to PCOS group (n=65, OV dissolved in sesame oil, 5 mg/0.4 ml), or to non-PCOS control group (n=7, sesame oil, 0.4 ml). After a month, ultrasound was performed to assess the ovarian morphology, and the results of an initial oral glucose tolerance test (OGTT) were used to identify the animals with altered glucose metabolism (AGM). Glucose transporter 4 (GLUT4) was evaluated from muscle biopsies, OS parameters were assessed from blood and muscle samples, and ovaries of 3 rats were removed for histopathological examination. Afterwards, the AGM group was divided in a treated PCOS group denoted as Sp+D (per os spironolactone dissolved in DMSO, 2 mg/0.2 ml), and a PCOS control treated with DMSO (0.2 ml). After one month of daily treatment, a final OGTT was performed. GLUT4 and OS parameters were again evaluated and ovaries were removed for histopathological examination.

As compared to the values prior to the treatment, Sp+D reversed fasting hyperglycaemia (p<0.001), increased GLUT4 immunoreactivity in the perinuclear compartment (p<0.05) and translocation to plasmalemma (p<0.001) and improved superoxide dismutase (0.001<p<0.01) and glutathione peroxidase (0.001<p<0.01) activities, while reducing GSH level (0.001<p<0.01). Administration of DMSO alone decreased fasting hyperglycaemia (p<0.001) and 2-h glucose level (p<0.05) independently of GLUT4 translocation, improved superoxide dismutase (p<0.001) and glutathione peroxidase (p<0.05) activities in erythrocytes, reduced GSH level in serum (p<0.05) and diminished lipid peroxidation in muscle as compared to the values recorded before treatment (0.001<p<0.01).

Our results showed that the Sp+D treatment improved antioxidant capacity and had a beneficial effect on metabolic deregulation in PCOS. Administration of DMSO had an unexpected hypoglycaemiant effect and improved OS parameters. This may represent an indirect proof of the role of oxidative stress and inflammation in PCOS and glucose metabolism abnormalities encountered in PCOS.

Key words

polycystic ovarian syndrome - fasting hyperglycaemia - glucose transporter 4 - oxidative stress - spironolactone - dimethylsulfoxide

* These authors contributed equally to this work.


 

  • References

  • 1 Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235-245
    CrossrefPubMedGoogle Scholar
  • 2 Azziz R, Woods KS, Reyna R et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749
    CrossrefPubMedGoogle Scholar
  • 3 Azziz R, Carmina E, Dewailly D et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488
    CrossrefPubMedGoogle Scholar
  • 4 Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obs Gynecol Surv 2004; 59: 141-154
    PubMedGoogle Scholar
  • 5 Hudecova M, Holte J, Olovsson M et al. Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome – a long term follow-up. Hum Reprod 2011; 26: 1462-1468
    CrossrefPubMedGoogle Scholar
  • 6 Gambineri A, Patton L, Altieri P et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes 2012; 61: 2369-2374
    CrossrefPubMedGoogle Scholar
  • 7 Karakas SE, Kim K, Duleba AJ. Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome. Diabetes Care 2010; 33: 887-893
    CrossrefPubMedGoogle Scholar
  • 8 Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787-790
    CrossrefPubMedGoogle Scholar
  • 9 Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625
    CrossrefPubMedGoogle Scholar
  • 10 Selva DM, Hogeveen KN, Innis SM et al. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest 2007; 117: 3979-3987
    PubMedGoogle Scholar
  • 11 Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci 2002; 102: 151-166
    CrossrefPubMedGoogle Scholar
  • 12 Corbould A. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?. Diabetes Metab Res Rev 2008; 24: 520-532
    CrossrefPubMedGoogle Scholar
  • 13 Meyer C, Pimenta W, Woerle HJ et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006; 29: 1909-1914
    CrossrefPubMedGoogle Scholar
  • 14 Lastra G, Whaley-Connell A, Manrique C et al. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am J Physiol Endocrinol Metab 2008; 295: E110-E116
    CrossrefPubMedGoogle Scholar
  • 15 Kulshreshtha B, Gupta N, Ganie MA et al. Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome – a retrospective analysis. Gynecol Endocrinol 2012; 28: 823-826
    CrossrefPubMedGoogle Scholar
  • 16 Homma T, Fujisawa M, Arai K et al. Spironolactone, but not eplerenone, impairs glucose tolerance in a rat model of metabolic syndrome. J Vet Med Sci 2012; 74: 1015-1022
    CrossrefPubMedGoogle Scholar
  • 17 Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzym 1994; 233: 357-363
    PubMedGoogle Scholar
  • 18 Conti M, Morand PC, Levillain P et al. Improved fluorometric determination of malonaldehyde. Clin Chem 1991; 37: 1273-1275
    PubMedGoogle Scholar
  • 19 Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276-287
    CrossrefPubMedGoogle Scholar
  • 20 Pippenger CE, Browne RW, Armstrong D. Regulatory antioxidant enzymes. Methods Mol Biol 1998; 108: 299-313
    PubMedGoogle Scholar
  • 21 Flohé L, Günzler WA. Assays of glutathione peroxidase. Method Enzym 1984; 105: 114-121
    PubMedGoogle Scholar
  • 22 Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzym 1994; 233: 380-385
    PubMedGoogle Scholar
  • 23 Filip A, Daicoviciu D, Clichici S et al. The effects of grape seeds polyphenols on SKH-1 mice skin irradiated with multiple doses of UV-B. J Photochem Photobiol B 2011; 105: 133-142
    CrossrefPubMedGoogle Scholar
  • 24 Noble JE, Bailey MJA. Quantitation of protein. Methods Enzym 2009; 463: 73-95
    PubMedGoogle Scholar
  • 25 Filip A, Clichici S, Daicoviciu D et al. Chemopreventive effects of Calluna vulgaris and Vitis vinifera extracts on UVB-induced skin damage in SKH-1 hairless mice. J Physiol Pharmacol 2011; 62: 385-392
    PubMedGoogle Scholar
  • 26 Clichici S, Biris AR, Tabaran F et al. Transient oxidative stress and inflammation after intraperitoneal administration of multiwalled carbon nanotubes functionalized with single strand DNA in rats. Toxicol Appl Pharmacol 2012; 259: 281-292
    CrossrefPubMedGoogle Scholar
  • 27 Ferrara DE, Weiss D, Carnell PH et al. Quantitative 3D fluorescence technique for the analysis of en face preparations of arterial walls using quantum dot nanocrystals and two-photon excitation laser scanning microscopy. Am J Physiol Regul Integr Comp Physiol 2006; 290: R114-R123
    CrossrefPubMedGoogle Scholar
  • 28 Pawley J. The 39 steps: a cautionary tale of quantitative 3-D fluorescence microscopy. Biotechniques 2000; 28: 884-886
    PubMedGoogle Scholar
  • 29 Price OT, Lau C, Zucker RM. Quantitative fluorescence of 5-FU-treated fetal rat limbs using confocal laser scanning microscopy and Lysotracker Red. Cytom A 2003; 53: 9-21
    PubMedGoogle Scholar
  • 30 Good MJ, Hage WJ, Mummery CL et al. Localization and quantification of epidermal growth factor receptors on single cells by confocal laser scanning microscopy. J Histochem Cytochem 1992; 40: 1353-1361
    CrossrefPubMedGoogle Scholar
  • 31 Nishiumi S, Ashida H. Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci Biotechnol Biochem 2007; 71: 2343-2346
    CrossrefPubMedGoogle Scholar
  • 32 Olteanu D, Nagy A, Dudea M et al. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats. J Physiol Pharmacol 2012; 63, 5: 483-496
    PubMedGoogle Scholar
  • 33 Stener-Victorin E, Lundeberg T, Waldenstro U et al. Effects of Electro-Acupuncture on Nerve Growth Factor and Ovarian Morphology in Rats with Experimentally Induced Polycystic Ovaries 1. Biol Reprod 2000; 63: 1497-1503
    CrossrefPubMedGoogle Scholar
  • 34 Neuhaus J, Schwalenberg T. Intravesical treatments of bladder pain syndrome/interstitial cystitis. Nat Rev Urol 2012; 9: 707-720
    CrossrefPubMedGoogle Scholar
  • 35 Amemori S, Iwakiri R, Endo H et al. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J Gastroenterol 2006; 41: 444-449
    CrossrefPubMedGoogle Scholar
  • 36 Salim AS. Allopurinol and dimethyl sulfoxide improve treatment outcomes in smokers with peptic ulcer disease. J Lab Clin Med 1992; 119: 702-709
    PubMedGoogle Scholar
  • 37 Jia Z, Zhu H, Li Y et al. Potent inhibition of peroxynitrite-induced DNA strand breakage and hydroxyl radical formation by dimethyl sulfoxide at very low concentrations. Exp Biol Med 2010; 235: 614-622
    CrossrefPubMedGoogle Scholar
  • 38 Heikkila RE. The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Eur J Pharmacol 1977; 44: 191-193
    CrossrefPubMedGoogle Scholar
  • 39 Ramesh B, Pugalendi KV. Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J Med Food 2006; 9: 562-566
    CrossrefPubMedGoogle Scholar
  • 40 Irshaid F, Mansi K, Aburjai T. Antidiabetic effect of essential oil from Artemisia sieberi growing in Jordan in normal and alloxan induced diabetic rats. Pak J Biol Sci 2010; 13: 423-430
    CrossrefPubMedGoogle Scholar
  • 41 Berenguer M, Zhang J, Bruce MC et al. Biochimie Dimethyl sulfoxide enhances GLUT4 translocation through a reduction in GLUT4 endocytosis in insulin-stimulated 3T3-L1 adipocytes. Biochimie 2011; 93: 697-709
    CrossrefPubMedGoogle Scholar
  • 42 Duleba AJ, Dokras A. Is PCOS an inflammatory process?. Fertil Steril 2012; 97: 7-12
    CrossrefPubMedGoogle Scholar
  • 43 Maddux BA, See W, Lawrence JC et al. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of alpha-lipoic acid. Diabetes 2001; 50: 404-410
    CrossrefPubMedGoogle Scholar
  • 44 Singh I, Carey AL, Watson N et al. Oxidative stress-induced insulin resistance in skeletal muscle cells is ameliorated by gamma-tocopherol treatment. Eur J Nutr 2008; 47: 387-392
    CrossrefPubMedGoogle Scholar
  • 45 Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006; 29: 1130-1139
    CrossrefPubMedGoogle Scholar
  • 46 Bensellam M, Laybutt DR, Jonas JC. The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions. Mol Cell Endocrinol 2012; 364: 1-27
    CrossrefPubMedGoogle Scholar
  • 47 Tiedge M, Lortz S, Drinkgern J et al. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997; 46: 1733-1742
    CrossrefPubMedGoogle Scholar
  • 48 Harasim E, Chabowski A, Górski J. Lack of downstream insulin-mimetic effects of visfatin/eNAMPT on glucose and fatty acid metabolism in skeletal muscles. Acta Physiol 2011; 202: 21-28
    CrossrefPubMedGoogle Scholar
  • 49 Wojtaszewski JFP, Jørgensen SB, Frøsig C et al. Insulin signalling: effects of prior exercise. Acta Physiol Scand 2003; 178: 321-328
    CrossrefPubMedGoogle Scholar